Sign In
Buy HOLX
$76.01
+0 (+0%)
At Close: Jul 06, 2026
Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now?
10:01am, Friday, 13'th Feb 2026
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Twin Capital Management Inc. Cuts Position in Hologic, Inc. $HOLX
03:22am, Monday, 09'th Feb 2026
Twin Capital Management Inc. decreased its position in Hologic, Inc. (NASDAQ: HOLX) by 77.5% during the undefined quarter, according to the company in its most recent disclosure with the Securities an
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio
08:15am, Wednesday, 04'th Feb 2026
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #FDA--Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio.
Hologic (HOLX) International Revenue Performance Explored
10:16am, Monday, 02'nd Feb 2026
Review Hologic's (HOLX) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
10:02am, Monday, 02'nd Feb 2026
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash
09:32am, Friday, 30'th Jan 2026
Hologic slips after a Q1 EPS and revenue miss, as gross margin fell 150 bps with Diagnostics weakness offset by strong GYN Surgical growth.
Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics
07:01pm, Thursday, 29'th Jan 2026
The headline numbers for Hologic (HOLX) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Hologic (HOLX) Misses Q1 Earnings and Revenue Estimates
06:26pm, Thursday, 29'th Jan 2026
Hologic (HOLX) came out with quarterly earnings of $1.04 per share, missing the Zacks Consensus Estimate of $1.09 per share. This compares to earnings of $1.03 per share a year ago.
Hologic Announces Financial Results for First Quarter of Fiscal 2026
04:02pm, Thursday, 29'th Jan 2026
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic Announces Financial Results for First Quarter of Fiscal 2026.
Stay Ahead of the Game With Hologic (HOLX) Q1 Earnings: Wall Street's Insights on Key Metrics
10:15am, Monday, 26'th Jan 2026
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Hologic (HOLX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:07am, Thursday, 22'nd Jan 2026
Hologic (HOLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Thursday, 22'nd Jan 2026
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Hologic Q1 Earnings Preview: How Should You Play the Stock Now?
09:51am, Thursday, 22'nd Jan 2026
HOLX heads into Q1 earnings with rising EPS and revenue estimates, strong segment momentum and a pending buyout limiting near-term upside.
Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Wednesday, 21'st Jan 2026
Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why Hologic (HOLX) is a Strong Momentum Stock
10:50am, Wednesday, 21'st Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
